WaveMan · Form 4
Goeltz II Robert C. insider trades
> Search tickers & screens ⌘K
LIVE

Goeltz II Robert C. insider trades

Goeltz II Robert C. has filed 18 Form 4s with the SEC that we hold, all for Arcus Biosciences, Inc. (RCUS), as Chief Financial Officer. Across all of them we count 0 purchases worth $0 and 17 sales worth $1.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 6 sales ($855.9K). The largest single trade was a sale of 7,763 shares of Arcus Biosciences, Inc. worth $199.0K, dated 2026-05-11. The first filing on our record is dated 2021-12-20 and the latest 2026-05-12.

Arcus Biosciences, Inc. (RCUS)

Chief Financial Officer · 18 filings · 17 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-12-16S, sale reported on Form 4354$14.0K2021-12-20
2021-12-16S, sale reported on Form 4131$5.3K2021-12-20
2021-12-17S, sale reported on Form 4138$5.4K2021-12-20
2021-12-17S, sale reported on Form 488$3.5K2021-12-20
2021-12-17S, sale reported on Form 4171$6.9K2021-12-20
2021-12-17S, sale reported on Form 4224$9.3K2021-12-20
2022-12-16S, sale reported on Form 4387$12.1K2022-12-16
2022-12-16S, sale reported on Form 42,066$63.3K2022-12-16
2023-06-07S, sale reported on Form 44,049$81.1K2023-06-09
2024-01-02S, sale reported on Form 42,004$40.1K2024-01-04
2024-12-31S, sale reported on Form 43,594$53.9K2025-01-03
2025-10-28S, sale reported on Form 45,000$100.0K2025-10-29
2025-11-26S, sale reported on Form 45,000$125.0K2025-11-26
2025-12-16S, sale reported on Form 46,702$146.6K2025-12-18
2025-12-17S, sale reported on Form 45,960$132.1K2025-12-18
2025-12-31S, sale reported on Form 46,552$153.2K2026-01-02
2026-05-11S, sale reported on Form 47,763$199.0K2026-05-12
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1653881) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms